Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — April 2017

Planlagt Fastgjort Låst Flyttet Genmab
2.0k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • G Offline
    G Offline
    GlobalMacro 0
    wrote on sidst redigeret af
    #1138

    Therefore I’m arguing the point that the full MM business is currently reflected in the stock price, I believe it is clearly not and the stock price will keep moving on positive MM news (for example: Pollux PFS updates, ORR / hazard ration in Alcyone study and faster than expected sales growth).

    1 Reply Last reply
    0
    • G Offline
      G Offline
      GlobalMacro 0
      wrote on sidst redigeret af
      #1139

      Therefore if the correct peak sales (15bn – 20bn) would already been verified by the analysts DCF models, they would show a much higher price target.
      It is simple math, we know the Pollux PFS is 50+ months, so why are they calculating with only half of this in their DCF models?

      1 Reply Last reply
      0
      • G Offline
        G Offline
        GlobalMacro 0
        wrote on sidst redigeret af
        #1140

        The current price targets should be way way higher.
        We’ll get there, only it’s going to take more time.

        1 Reply Last reply
        0
        • G Offline
          G Offline
          GlobalMacro 0
          wrote on sidst redigeret af
          #1141

          If you’re not sure if this is right I suggest you take an analyst report that has a full P&L up to 2025 (Citi Bank, Kempen, Nordea) and look how the peak sales of Dara is build up, you’ll see that their assumptions are way way to conservative.

          1 Reply Last reply
          0
          • G Offline
            G Offline
            GlobalMacro 0
            wrote on sidst redigeret af
            #1142

            @Bikube, regarding the Carina trial.
            I get your view on the current sell-off, however I believe this in no case reflects a normal market reaction and this will not be how the market on average will react in the future if certain studies with the little magnitude like the Carina study fail. What happened in the rollercoaster from 1413 till 1220 just doesn’t make any sense. I think some part of it was manipulated and we’ll see 1400 within a couple of weeks.

            1 Reply Last reply
            0
            • J Offline
              J Offline
              JKY_VH
              wrote on sidst redigeret af
              #1143

              Thank you GM. I am assuming that you are not employed by HSBC:-)

              1 Reply Last reply
              0
              • B Offline
                B Offline
                bibob
                wrote on sidst redigeret af
                #1144

                He suddently is not 🙂

                1 Reply Last reply
                0
                • G Offline
                  G Offline
                  GlobalMacro 0
                  wrote on sidst redigeret af
                  #1145

                  haha!

                  1 Reply Last reply
                  0
                  • BudweisB Offline
                    BudweisB Offline
                    Budweis
                    wrote on sidst redigeret af
                    #1146

                    http://www.journalofclinicalpathways.com/article/daratumumab-cost-effective-refractory-multiple-myeloma

                    1 Reply Last reply
                    0
                    • BudweisB Offline
                      BudweisB Offline
                      Budweis
                      wrote on sidst redigeret af
                      #1147

                      Daratumumab Cost-Effective for Refractory Multiple Myeloma

                      1 Reply Last reply
                      0
                      • Helge_LarsenPI-redaktørH Offline
                        Helge_LarsenPI-redaktørH Offline
                        Helge_LarsenPI-redaktør
                        wrote on sidst redigeret af
                        #1148

                        God morgen. 🙂

                        1 Reply Last reply
                        0
                        • Helge_LarsenPI-redaktørH Offline
                          Helge_LarsenPI-redaktørH Offline
                          Helge_LarsenPI-redaktør
                          wrote on sidst redigeret af
                          #1149

                          Tak for link Bud. 🙂

                          1 Reply Last reply
                          0
                          • B Offline
                            B Offline
                            bibob
                            wrote on sidst redigeret af
                            #1150

                            God morgen. 🙂

                            1 Reply Last reply
                            0
                            • B Offline
                              B Offline
                              bibob
                              wrote on sidst redigeret af
                              #1151

                              Tak for link Budweis. Ser ud til at FDA er blevet mere prisbevidste. Godt for DARA.

                              1 Reply Last reply
                              0
                              • J Offline
                                J Offline
                                JKY_VH
                                wrote on sidst redigeret af
                                #1152

                                Tak Budweis og god morgen

                                1 Reply Last reply
                                0
                                • B Offline
                                  B Offline
                                  bibob
                                  wrote on sidst redigeret af
                                  #1153

                                  http://www.journalofclinicalpathways.com/basic-page/best-therapy-combination-multiple-myeloma

                                  1 Reply Last reply
                                  0
                                  • B Offline
                                    B Offline
                                    bibob
                                    wrote on sidst redigeret af
                                    #1154

                                    http://www.journalofclinicalpathways.com/article/meta-analysis-reveals-optimal-combination-therapy-multiple-myeloma

                                    1 Reply Last reply
                                    0
                                    • T Offline
                                      T Offline
                                      transalp
                                      wrote on sidst redigeret af
                                      #1155

                                      Tak for dagens link.. Godt at se dara er fornuftigt prissat..

                                      1 Reply Last reply
                                      0
                                      • G Offline
                                        G Offline
                                        gentogen
                                        wrote on sidst redigeret af
                                        #1156

                                        Tak for super links og den fine søndagschat. Jeg tør næsten ikke dele Global Macros optimisme, men er nu sådan set meget enig i de grundlæggende tanker

                                        1 Reply Last reply
                                        0
                                        • E Offline
                                          E Offline
                                          E_L
                                          wrote on sidst redigeret af
                                          #1157

                                          http://www.newswire.ca/news-releases/janssen-inc-receives-health-canada-approval-of-darzalex-daratumumab-by-priority-review-for-patients-with-multiple-myeloma-who-have-had-at-least-one-prior-therapy-619600403.html Janssen Inc. Receives Health Canada Approval of DARZALEX® (daratumumab) by Priority Review for Patients with Multiple Myeloma Who Have Had At Lea
                                          st One Prior Therapy

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger